702-827-2727 [email protected]


  • CJC1295/Ipamorelin is the combination of two compounds, CJC1295 and Ipamorelin
  • CJC 1295 is prescribed as a Growth Hormone Releasing Hormone (GHRH) analog that acts on the pituitary
  • Ipamorelin is prescribed as a selective Growth Hormone Secretagogue that also acts on the pituitary
  • These two combinations act together to increase Human Growth Hormone by acting on two different families of receptors
  • It is best prescribed to be taken before bed on an empty stomach
  • CJC 1295/Ipamorelin is normally prescribed at night to maximize the body’s natural cycle of growth hormone and stimulate the pituitary gland during REM sleep

The increased volume of human growth hormone (hGH) produced by the pituitary gland have shown to cause an increase in the production of Insulin-Like Growth Factor-1 (IGF-1) by the liver and results in several health benefits such as:

    • Decreased body fat
    • Increased muscle mass
    • Increased strength
    • Improved energy & strength
    • Improved quality of sleep
    • Helped combat insomnia
    • Increased physical and mental performance
    • Enhanced calcium retention
    • Bone density Improved
    • Improved immune function
    • Improved fat burning
    • Improved skin elasticity
    • Aided in connective tissue repair post injury



    Benefits for patients on CJC1295/Ipamorelin shown over the first six weeks of protocol may include improvements in:

     Week 1       Better quality of sleep

    Week 2        Faster recovery from workouts

    Week 3        Mental Clarity

    Week 4        Improved skin elasticity

    Week 5           Improved body composition



    CJC1295/Ipamorelin should not be used while pregnant or breastfeeding. Always tell your physician about all medications and supplements, especially corticosteroids and thyroid medications, that you are taking. Common side effects of CJC1295/Ipamorelin include reactions at the injection site, such as pain, redness or swelling along with flushing of the face; and less than 1 percent of patients report dizziness, headache or hyperactivity.



    The combination of CJC 1295 and Ipamorelin has been developed because the two can act together on the pituitary and hypothalamus to increase levels of growth hormone in your body. It is done in this way to maximize the amount of growth hormone being released into your body for therapeutic benefit while acting on two separate families of receptors.